Synthetic biology: From the first synthetic cell to see its current situation and future development by LiuYan Zhang et al.
   
 
© The Author(s) 2011. This article is published with open access at Springerlink.com csb.scichina.com   www.springer.com/scp 
Invited Review 
SPECIAL TOPICS:  
Bioengineering January 2011  Vol.56  No.3: 229–237 
 doi: 10.1007/s11434-010-4304-z 
Synthetic biology: From the first synthetic cell to see its current 
situation and future development 
ZHANG LiuYan, CHANG SuHua & WANG Jing* 
Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China 
Received July 29, 2010; accepted October 19, 2010 
 
Synthetic biology is an emerging field, which, since its birth, has shown great value and potential in many fields including medi-
cine, energy, environment and agriculture. It is also important for the study of the origin and evolution of life. Since the publica-
tion of the first synthetic cell in May, 2010, synthetic biology again attracts high attention and leads to extensive discussions all 
over the world. There have been a number of researches and achievements on synthetic biology in the United States and European 
countries. While in China, so far there is no systematic research on synthetic biology. In order to promote the development of this 
new discipline in China, we organized this review to systematically introduce the concept and research content of synthetic bio- 
logy, summarize the achievements, and investigate the current situation in both China and abroad. We also analyzed the opportu-
nities and challenges in synthetic biology, and looked forward to the future development of synthetic biology, especially its future 
development in China. 
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On May 21, 2010, researchers in J. Craig Venter Institute 
(JCVI) published on Science their latest achievement on the 
creation of the first synthetic cell, as labeled JCVI-syn1.0, 
which was controlled by a completely chemically synthe-
sized genome [1]. This achievement upon its publication 
has brought great concerns and extensive discussions in 
both scientific community and social society. The birth of 
the first synthetic cell indicates an important breakthrough 
in synthetic biology, which is an emerging field showing 
great value and potential in many fields, including medi-
cine, energy, environment and agriculture. According to the 
report by The Royal Academy of Engineering of United 
Kingdom in 2009, it is expected that synthetic biology will 
create new significant industries, and the development of 
this field will have great impact on the future economy of 
United Kingdom, Europe and even all over the world [2]. 
Researchers from a wide range of disciplines, including  
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biology, computer science, engineering and mathematics, 
have been attracted to devote themselves to the research of 
synthetic biology. Numerous projects on synthetic biology 
have been proposed. A flourish of synthetic biology has 
been envisioned especially in Europe and USA. In order to 
promote the development of synthetic biology in China, 
here in this article, we made a systematic review on syn-
thetic biology, including its basic concept, research content, 
and key achievements. We also investigated its current 
situation in both China and abroad. At last, we analyzed the 
opportunities and challenges in synthetic biology, and 
looked forward to the future development of synthetic biol-
ogy, especially its future development in China. 
1  An overview of synthetic biology 
1.1  Concept 
The definition of synthetic biology keeps evolving with a 
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decade of development. So far there is no official or formal 
definition. According to the definition from the Synthetic 
Biology Community (http://syntheticbiology.org/), which is 
the most widely accepted concept, synthetic biology is the 
design and construction of new biological parts, devices and 
systems and the re-design of existing natural biological sys-
tems for useful purposes. Synthetic biology on the one hand 
is important to explore the origin and evolution of life, on 
the other hand, it has a broad range of applications ranging 
from health care (diagnostics and therapeutics), environ-
ment (biosensors, bioremediation), energy (biofuel) to agri-
culture (optimized food), through engineering the biological 
systems or modules [2–5]. One of the key features of syn-
thetic biology is to apply the engineering principles to bio-
logical studies. The pipeline for engineering design, de-
scribed as specification, design, modeling, implementation 
and testing/validation, was introduced into the design and 
construction of biological systems (Figure 1). Under the 
principle of synthetic biology, the complex life system can 
be treated as an organic combination of various functional 
elements. Synthetic biology starts from specification and 
standardization of biological parts, and then assembles the 
parts into devices and systems step by step [6]. The stan-
dardization of biological parts helps to improve the control-
lability and predictability of designed modules. Figure 2 
shows the feature of synthetic biology and its difference in 
comparison to traditional genetic engineering. 
The origin and development of synthetic biology are 
based on the development of current science and technolo-
gies including biotechnology, computer science, chemistry 
and so on. Meanwhile, the development of synthetic biology 
also fosters the birth of new science and technology. 
Knowledge from genomics, genetics, molecular biology, 
cell biology and systems biology facilitates our understanding 
on life system; skills from bioinformatics, computer science 
 
Figure 1  Engineering Cycle. The Engineering Cycle starts with defining 
the specification for the device or system which is to be designed and built. 
The next step in the process is to design the device or system on the basis 
of the specification. Frequently in engineering the design is then tested by 
extensive modeling. In the case of synthetic biology this is almost always 
an important step. Modeling is followed by implementation, testing and 
validation [6]. 
 
Figure 2  A representation of the design process of traditional genetic 
engineering (a) and synthetic biology (b). Both traditional genetic engi-
neering and synthetic biology employ naturally occurring and modified 
biological components to construct an engineered system. However, be-
cause the building blocks and assembly methods of traditional genetic 
engineering methods are not well characterized, they often result in unan-
ticipated interactions that can lead to suboptimal integration and pleiotropic 
effects when assembled into a larger system. This means that the output is 
frequently unpredictable and strongly dependent upon both the selection of 
specific parts and the methods for assembly. By contrast, synthetic biology 
begins with developing standardized biological components, with stan-
dardized interfaces that are fixed to promote optimal integration. The result 
should be highly predictable engineered systems with a single output for a 
single input [5]. 
and mathematics provide technical support on life design; 
while accumulated experiences on genetic and metabolic 
engineering etc. enable the process of life engineering. 
Synthetic biology can not only optimize life, but also can 
create new life. In this respect, we may regard synthetic 
biology as a revolutionarily new biotechnology. 
1.2  Main research contents 
Synthetic biology aims to synthesize new life form or engi-
neer the existing life for useful purposes. Current researches 
are mainly focused on 3 aspects: (1) standardization of 
bio-parts and the design and construction of biological 
modules; (2) minimal genome; and (3) synthetic genomics.  
(i) Standardization of bio-parts and the design and con-
struction of biological modules.  A bio-part, or BioBrick, 
usually refers to a short segment of DNA which acts as a 
promoter, terminator, protein coding sequence, or any other 
functional element. Standardization of bio-parts is a process 
to characterize and specify the bio-parts, including a de-
tailed description and quality control testing by following 
certain standards. The highly characterized bio-parts make 
the design and construction of biological modules (devices, 
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systems) much easier. The interaction of various elements 
in biological system is similar to that in electronic system. 
Based on these similarities, genetic circuits were designed 
and constructed (Figure 3). The design and construction of 
biological modules not only include the de novo design and 
construction of new biological modules, but also the 
re-design of the existing natural biological systems. 
(ii) Minimal genome.  Newly designed/re-designed 
bio-modules need to be loaded into a proper vector (chassis) 
to express and function. An ideal chassis is supposed to 
have a simplified but robust genome, i.e. “minimal ge-
nome”, to reduce background noise and complexity, and to 
improve predictability and controllability of the new sys-
tem. A minimal genome is a collection of essential gene 
contents which has the ability to sustain normal cellular life 
under ideal conditions, that is, in the presence of a full com-
plement of essential nutrients and in the absence of envi-
ronmental stress [8]. So the key question for minimal ge-
nome research is to identify the essentiality of genes. Usu-
ally there are two strategies [9] to get a minimal genome: 
the top-down strategy which aims to delete the non-essential 
segments from existing natural genomes, and the bottom-up 
strategy which obtains a minimal genome by de novo syn-
thesis and assembly of essential genes. It should be noted 
that here the “minimal genome” is not an absolute concept 
but a relative concept in comparison to natural genomes. 
Usually the living condition and research objective help 
define the boundary of a minimal genome [10]. It is hard to 
get a universal chassis suitable for different research or ap-
plication purposes. With more microbial genomes being 
sequenced, the rich database of genome sequences, as well 
as the rapid development of DNA sequencing and synthesis 
techniques, provide strong foundations for the construction 
of minimal genomes. 
(iii) Synthetic genomics.  This includes the design,  
chemical synthesis and assembly of whole genome. Sequenc-
ing technology endows us to read the genome to understand 
life forms, computational modeling and simulation facilitate 
the in silico design, while DNA synthesis technology en-
ables us to write the genome for new life forms. So a sys-
tematic technical system on synthetic genomics is an im-
portant premise for the development of synthetic biology. 
2  Current research situation of synthetic   
biology 
Since year 2000, driven by Drew Andy, Jay D. Keasling, 
James J. Collins et al., progresses have been made in 
bio-parts standardization and genetic circuit design. The 
establishment of The BioBricks Foundation (http://open- 
wetware. org/ wiki/The_BioBricks_Foundation) and Regis-
try of Standard Biological Parts (http://partsregistry.org/ 
Main_Page) further promote the development of this area. 
The minimal genome and synthetic genomics research in 
JCVI also made big achievements. The recent publication 
on the first synthetic cell represents a milestone in synthetic 
biology. Meanwhile, there are more than ten genome reduc-
tion projects have been finished and the corresponding 
techniques have been developed and are getting mature. 
2.1  Standardization of bio-parts and the design and 
construction of biological modules 
In year 2000, the successful synthesis of genetic toggle 
switch [11] and genetic repressilator [12] represent the be-
ginning of synthetic biology [13]. In 2003, the Synthetic 
Biology Community and the Registry of Standard Biologi-
cal Parts were founded in Massachusetts Institute of Tech-
nology (MIT). In 2004, the first International Genetically  
 
Figure 3  From electronic systems to engineered synthetic biology systems. Switches and oscillators that occur in electronic systems are also seen in biol-
ogy and have been engineered into synthetic biological systems [7]. 
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Engineered Machine Competition (iGEM) was held in MIT. 
The BioBricks Foundation (BBF) was established and the 
first International Meeting on Synthetic Biology was held in 
the same year. iGEM is a worldwide Synthetic Biology 
competition aimed at undergraduate students. Till 2010, 
there have been more than 120 teams from different coun-
tries participating it including about 2000 participants. Uni-
versities from China have participated this competition 
since 2007 and have made outstanding achievements. Major 
events [14] on bio-parts standardization and genetic circuit 
design are listed in Table 1. 
There are several successful researches on genetic circuit 
design. It is worth to mention that the research team led by 
Jay D. Keasling [17,22] successfully engineered bacterium 
to produce the chemical precursor of artemisinin – the best 
drug available today to cure malaria. Multiple genes from 
bacterium, yeast and plant were involved and designed to 
make an engineered organism which has the ability of pro-
ducing artemisinic acid with high efficiency. Once this 
achievement was applied to industrial production, the cost 
of anti-malaria drug would be greatly reduced. This event 
also indicates the great value and prospect of synthetic bi-
ology in medicine field. 
Researches aiming for biofuel production using synthetic 
biology techniques were also proposed. In 2007, Zhang et 
al. [28] published their results of high-yield hydrogen pro-
duction from starch and water by a synthetic enzymatic 
pathway under mild reaction conditions. In 2010, Keasling 
and his colleagues [29] implemented the microbial produc-
tion of fatty-acid-derived fuels and chemicals from plant 
biomass using synthetic biology techniques. Both of these 
achievements indicate the great potential of synthetic biol-
ogy on green energy production. 
2.2  The minimal genome research 
The minimal genome research began in year 1995 with the  
publication of the genome sequence of Mycoplasma geni-
talium, which is regarded to have the smallest genome 
among free-living organisms [30]. The genome size of M. 
genitalium is 580 kb coding about 480 genes. This inspired 
scientists to seek for a minimal genome which can sustain a 
normal cellular life. In addition, minimal genome study 
provides an important perspective to explore the mystery of 
the origin and evolution of life. 
One of the key points of minimal genome research is to 
define the essentiality of genes for a cell. Comparative ge-
nomics [31,32], large-scale gene inactivation experiments 
[33–38], and network-based prediction [39] have been used 
to identify essential genes. Studies related to essential genes 
have been reviewed in refs [10,40]. After experimental 
identification, results show that even in the genome of M. 
genitalium, there are about 100 protein coding genes re-
garded as non-essential [34]. Researches on E. coli or B. 
subtilis show that no more than ten percents of genome con-
tent are essential for both of them [36,41].  
Some genome reduction projects have been finished by 
using different strategies. The most common methods are 
suicide plasmid-mediated genomic deletion, linear DNA- 
mediated genomic deletion, site-specific recombination- 
mediated genomic deletion, and transposon-mediated ran-
dom deletion. The detail description of these methods can 
be found in refs [40,42]. Summary of the finished genome 
reduction projects are listed in Table 2. 
2.3  The design, synthesis and assembly of whole   
genome 
(i) Synthesis of viral genome.  During 1970s, the estab-
lishment and development of DNA synthesis and recombi-
nant DNA technologies had greatly promoted the research 
of genetic engineering and related biological studies. In 
1970, Agarwal et al. [55] at the first time chemically syn-
thesized the gene for an alanine transfer ribonucleic acid  
Table 1  Major events on bio-parts standardization and genetic circuit design 
Year Event 
2000 The first genetic toggle switch and repressilator were constructed by Gardner et al. [11] and Elowitz et al. [12], respectively. 
2002 The directed evolution of genetic circuits [15] and the stochastic gene expression in a single cell [16] were achieved. 
2003 Students from MIT and Cambridge University designed biological oscillators based on the Elowitz repressilator. 
A mevalonate pathway was engineered in Escherichia coli for the production of terpenoids which is a precursor to artemisinin [17]. 
The Synthetic Biology community and the Registry of Standard Biological Parts were established. 
2004 The first iGEM was held in MIT.  
The First International Meeting on Synthetic Biology was held in MIT.  
Programmed bacterial population control [18] and a mammalian toggle switch [19] were achieved. 
2005 Programmed pattern formation [20] and the artificial cell-cell communication in yeast [21] were achieved. 
2006 Production of the anti-malarial drug precursor artemisinic acid in engineered yeast [22] was achieved. 
2007 RNAi and the repressor protein switch [23], RNAi-based logic circuits [24] and ribosome switches were achieved [25].  
For the first time, Chinese students participated in the iGEM competition. Team from Peking University won the Grand Prize [26], and team from 
University of Science and Technology of China won the award of “Best Foundational Tech.” 
2008 Logic gates were created by chemical complementation with transcription factors [27]. 
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Table 2  Summary of genome reduction projects [42] 
Strain Deletion size Deleted functions(D) and new characteristics(C) 
Escherichia coli   
 Δ20-4 218.7 kb (5.6%) [43] (D) Random genomic regions 
 CDΔ3456 313.1 kb (6.7%) [44] (D) Nonspecific target regions 
   (C) Presentation of mutually exclusive regions 
 MDS12 376.1 kb (8.1%) [45] (D) K-strain-specific islands 
   (C) No significant difference to the parent cell 
 MDS43 708.3 kb (15.3%) [46] (D) K-islands, mobile elements 
   (C) Increased genome stability and electroporation efficiency 
 MGF-01 1.03 Mb (22%) [47] (D) Nonessential regions without growth deficiency 
   (C) Increased threonine production (2-fold) 
 Δ16 1.38 Mb (29.7%) [48] (D) Nonessential genes in the literature 
   (C) Growth deficiency, abnormal nucleoid location 
Bacillus subtilis   
 Δ6 320 kb (7.7%) [49] (D) Prophage, polyketide synthesis 
 MG1M 991 kb (24%) [50] (D) Prophage, polyketide synthesis, secondary metabolites 
   (C) Growth deficiency 
 MGB874 873.5 kb (20.7%) [51] (C) Increased productivity of extracellular cellulose (1.7-fold) and protease (2.5-fold) 
Corynebacterium glutamicum 190 kb (5.7%) [52] (D) R-strain-specific regions 
Schizosaccharomyces pombe ~500 kb (4%) [53] (C) Growth at a lower rate 
Saccharomyces cerevisiae 531.5 kb (5%) [54] (C) Increased production of ethanol (1.8-fold) and glycerol (2-fold) 
 
from yeast. The gene was composed of 77 nucleotides. Af-
ter that, DNA synthesis technology developed fast, and a 
variety of active viral genomes were synthesized (Table 3). 
(ii) Synthesis of bacterial genome.  In comparison to 
viruses, bacteria usually have bigger genomes and higher 
complexity. Venter and his team in JCVI spent 15 years in 
creating the first synthetic cell with the ability of 
self-replication. In general, there are 3 major technical 
challenges [60]: (1) De novo chemical synthesis and 
self-assembly of a complete genome; (2) genome transplan-
tation between cells, prokaryotic or eukaryotic, to make the 
transplanted genome control the receptor cell; and (3) trans-
plantation of a synthesized genome to a cell and make the 
donor genome control the receptor cell. Some other chal-
lenges also need to be tackled, such as the test of SNPs, 
quality control of DNA synthesis, DNA methylation, etc. It 
is estimated that about 40 million U.S. dollars were spent 
with over a decade efforts from 20 people for creation of 
such a synthetic cell [61]. Historical events of the synthetic 
genomic study in JCVI are listed in Table 4. 
The synthetic genome was designed based on the ge-
nome sequence of M. mycoides. To distinguish the synthetic 
genome from the natural one, 4 watermark sequences were 
designed to replace one or more cassettes in regions not 
interfering with cell viability [1]. The synthetic genome was 
produced with 1078 of 1080-bp cassettes which covered the 
whole designed genome. These cassettes were all chemi-
cally synthesized, and the ends of each cassette had 80-bp 
overlaps to adjacent cassettes to facilitate their assembly. A 
three-stage strategy was utilized to assemble the genome 
from these cassettes by transformation and homologous 
recombination in yeast. First, 109 of 10080-bp assemblies 
were stitched, then 11 of 100000-bp assemblies, and finally 
the complete genome with 1077947-bp length. The intact 
synthetic M. mycoides genomes from the yeast were trans-
planted into the restriction-minus M. capricolum recipient 
cells by using techniques described in ref. [66]. After cul-
turing and selection, a blue colony of bacteria was found to 
rapidly grow on a lab plate, which was subsequently identi-
fied as the synthetic transplants. 
Table 3  Summary of viral genome synthesis 
Timea) Event Genome size (kb) 
Aug. 2002 Chemical synthesis of poliovirus cDNA without natural template [56] 7.5 




Synthesis of the genome which present enhanced virulence of influenza: A viruses with the haemagglutinin  
of the 1918 pandemic virus [58] 
1.7(HA)+1.4(NA) 
Dec. 2008 Synthesis of a recombinant bat SARS-like corona-virus [59] 29.7 
a) According to the publish date of the results. 
234 Zhang L Y, et al.   Chinese Sci Bull   January (2011) Vol.56 No.3 
Table 4  Historical events of the synthetic genomic study in JCVI 
Timea) Event 
Oct. 1995 The whole genome sequencing of Mycoplasma genitalium was completed [30] 
Dec. 1999 
After identified by global transposon mutagenesis, it is estimated that there are about 265–350 genes are essential in  
the genome of M. genitalium [62] 
Dec. 2003 Generating a synthetic genome by whole genome assembly in two weeks: ΦΧ174 bacteriophage from synthetic oligonucleotides [57] 
Jan. 2006 Identified 382 essential genes among 482 coding sequences of M. genitalium by using single gene mutation [34] 
Aug. 2007 Genome transplantation in bacteria: Changing one species to another [63] 
Jan. 2008 Complete chemical synthesis, assembly, and cloning of a M. genitalium genome [64] 
Dec. 2008 One-step assembly in yeast of 25 overlapping DNA fragments to form a complete synthetic M. genitalium genome [65] 
Sep. 2009 Creating bacterial strains from genomes that have been cloned and engineered in yeast by using genome transplantation techniques [66] 
May 2010 Creation of a bacterial cell controlled by a chemically synthesized genome [1] 
a) According to the publish date of the results. 
 
The creation of the first synthetic cell is an important 
milestone in the development process of synthetic biology. 
Through this work, a technical system (or to say, a toolkit) 
including genome design, chemical synthesis and assembly, 
and genome transplantation were established, which can be 
utilized for further research and applications.  
3  Development status of synthetic biology 
3.1  Synthetic biology in Europe and United States 
Synthetic biology, as a newly emerging field, has gained 
great attention since its birth. In 2004, synthetic biology was 
elected as one of the top ten new techniques by Technique 
Review in U.S. In 2007, a research report named “Genome 
Synthesis and Design Futures: Implications for the U.S. 
Economy” was published by Bio-era of U.S. In 2008, “Cre-
ating Life” was listed as one of the Top Ten Scientific Dis-
coveries by Times. In May 2009, the Royal Academy of 
Engineering in U.K. released the report named “Synthetic 
Biology: scope, applications and implications”, in which a 
systematic introduction, the application prospects and social 
impact of synthetic biology were illustrated. During the last 
decade, U.S. and European countries have invested a huge 
amount of money to support the development of synthetic 
biology. 
After the Human Genome Project (HGP), the U.S. De-
partment of Energy started the “Genome To Life” project, 
which included the synthetic genomics research. In 2006, 
the Synthetic Biology Engineering Research Center (Syn-
BERC) was founded by funding from U.S. National Science 
Foundation. The partner institutions of SynBERC include 
UC Berkeley, UC San Francisco, Harvard, MIT, Stanford, 
and Prairie View A&M University. In Europe, in 2005, 
European Commission published the project report named 
“Synthetic Biology: Applying Engineering to Biology” as a 
part of the 6th Framework Programme. Later in 2007, the 
European Commission started 18 leading projects on syn-
thetic biology. In U.K., synthetic biology was listed as 
high-priority funded research field by Biotechnology and 
Biological Sciences Research Council (BBSRC) in 2008. 
Investigation report released by The Woodrow Wilson In-
ternational Center for Scholars on June 4th 2010 shows that 
since 2005, the U.S. government has spent approximately 
$430 million on synthetic biology projects. For comparison, 
the European Commission and 3 European countries, 
namely the Netherlands, the United Kingdom and Germany, 
have spent approximately $160 million on synthetic biology 
research (Figure 4). The funding keeps increasing in all 
these western countries. 
3.2  Synthetic biology in China 
Synthetic biology also attracts big attention and enthusiasm 
from scientists in China. The theme “Artificial Life” was 
listed in the 50-year scientific development roadmap by the 
Chinese Academy of Sciences (CAS). In February 2008, the 
Xiangshan Conference on synthetic biology was held by 
professor ZHANG ChunTing from Tianjin University, pro-
fessor WEI JiangChun from Institute of Microbiology, 
CAS, and Professor SUN ZhiRong from Tsinghua University. 
This is the first academic conference about synthetic biol-
ogy in China. In July 2009, the Key Laboratory of Synthetic 
 
Figure 4  The annual spending of the U.S. government agencies, the 
European Commission and 3 individual European countries (from http:// 
www.synbioproject.org/library/publications/archive/researchfunding/). 
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Biology of CAS organized a forum on the design of drug 
and energy products based on synthetic biology techniques. 
Beijing Institute of Life Science, CAS organized two fo-
rums on synthetic biology in Aug. and Nov. 2009, respec-
tively. A group of academicians, experts and scholars were 
invited to discuss the current status and development strate-
gies of synthetic biology aiming to promote its development 
in China. In Dec. 2009, the Eastern Technology Forum 
named “Basic and Frontier Issues of Synthetic Biology” 
was held and co-organized by Shanghai Jiao Tong Univer-
sity (SJTU) and Shanghai Institutes for Biological Sciences, 
CAS. In July 2010, supported by China Association for 
Science and Technology (CAST), the academic seminar on 
“Ethics and Bio-security Issues of Synthetic Biology” was 
held in Suzhou. Meanwhile, some research centers about 
synthetic biology were established, including the Systems 
and Synthetic Biology Research Center in Tianjin Univer-
sity, Key Laboratory of Synthetic Biology of CAS and the 
Synthetic Biology and Bioinformatics Center in the Acad-
emy of Military Medical Sciences. 
Chinese researchers have received some achievements on 
synthetic biology as well. For example, the bioinformatics 
center of Tianjin University built the Database of Essential 
Genes (DEG) to collect the published experimental essential 
genes and provide alignment service [67,68]. Scientists 
from the Key Laboratory of System Bioengineering in 
Tianjin University designed, simulated and constructed an 
environment-sensitive synthetic microbial ecosystem which 
provides valuable information for addressing questions in 
ecology and may act as a chassis for construction of more 
complex microbial ecosystems [69]. Research team from 
Ministry of Education Key Laboratory of Bioinformatics in 
Tsinghua University realized the reverse engineering of 
bacterial chemotaxis pathway by employing control theory 
and frequency domain analysis [70]. The iGEM team in 
Peking University continued their awarded project and syn-
thesized a novel genetic sequential logic circuit: A push-on 
push-off switch which has the ability to generate different 
outputs in response to the same input signal on the basis of 
its internal state, and “memorize” the output [26]. Re-
searchers from University of Science and Technology of 
China (USTC) developed and demonstrated reusable and 
combinable designs for transcriptional logic gates which 
laid foundation for the reuse and combinational design in 
synthetic biology [71]. On the other hand, Chinese scientists 
also actively participated in international collaboration on 
synthetic biology research. For example, research team 
from Institute of Psychology, CAS participated in the syn-
thetic biology project, the Programmable Bacterial Catalysts 
(PROBACTYS), of the 6th Framework Programme of Euro-
pean Union. As the only research team from non-European 
countries, they made great contribution on genome-scale 
metabolic network reconstruction and modelling. 
College students in China have also engaged in the study 
and research of synthetic biology. Recent years, there have 
been many teams from Peking University, Tsinghua Univer-
sity, USTC, Tianjin University and SJTU participating the 
iGEM competition, and have made remarkable achiev- ements. 
Chinese scientists have made great achievements on synthetic 
insulin and synthetic tRNA, which can be regarded as the ear-
lier foundation of synthetic biology. The development of sci-
ence and technology in China has shown that China has the 
ability to make more achievements in synthetic biology. 
4  Opportunities and challenges of synthetic  
biology 
Synthetic biology has shown us its great potential and pros-
pects in both basic and applied research, as well as its prom-
ising applications to improve human life, such as cheaper 
drug, faster disease diagnosis, efficient production of green 
energy, air cleaning and so on. However, there are still many 
challenges for the further development of synthetic biology.  
4.1  Technical challenges 
A publication on Nature listed 5 hard truths for synthetic bi-
ology: many of the parts are undefined; the circuitry is some-
times unpredictable; the complexity is still unwieldy; many 
parts are incompatible; variability may crash the system [72, 
73]. The key point lies in our still limited understanding of 
cellular life. HGP brought the -omics idea into biology sci-
ence. Different levels of -omics studies have generated plenty 
of data, which provide sound foundation for novel biological 
discoveries. Life is a complex networking system, including 
the interaction and communication between different net-
works of metabolism, transcription regulation and signal 
transduction. How to utilize the -omics data to generate a 
systematic and global knowledge about life are crucial to 
overcome the challenges currently we are facing. 
On the other hand, how to effectively integrate the current 
research findings on synthetic biology is a key step to pro-
mote the development of synthetic biology. Moreover, during 
the first decade of synthetic biology, most researches focused 
on single module design. How to combine the different single 
modules to perform more complex functions is another key 
point to overcome. For example, the combined modules are 
supposed to produce green energy while consuming pollut-
ants, or to detect and kill cancer cells [14]. Meanwhile, study 
on minimal genomes also plays an important role in future 
development of synthetic biology. Minimal genome study 
can not only provide proper chassis for newly designed mod-
ules, but also provide clues for exploring life forms. 
4.2  Social and ethical issues 
Science is always like a double-edged sword. While   
mentioning synthetic life or synthetic biology, some people 
do feel worried. Especially in 2008, when Becker et al. 
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synthesized the SARS virus, it caused the panic in the pub-
lic. People cannot help challenging that if such technology 
was managed by terrorists, what will happen? This year, 
when Venter’s team in JCVI announced that they created 
the first synthetic cell, the panic was raised again in the 
public. On May 27, 2010, J. Craig Venter made a testimony 
before the U.S. House of Representatives Committee on 
Energy and Commerce. Venter said that all their studies 
adhered to the state regulations. They have made extensive 
discussions on the bio-security and bio-safety implications 
of synthetic genomics and they have also explored the risks 
and benefits of the emerging technology, as well as possible 
safeguards to prevent abuse.  
Actually, from the technical point of view, scientists 
have predicted the potential risks and also have had preven-
tive measures. For example, the suicide gene can be used to 
kill the engineered cell once it developed in a wrong way; 
some designed cell can only survive under certain condi-
tions, and some engineered cell only has limited age. On the 
other hand, from the social point of view, regulations on 
bio-security and bio-safety should be proposed. First, gov-
ernment should strengthen the management. Second, scien-
tists should fulfill their responsibility to prevent the abuse of 
such techniques. Third, the public should be educated to 
have a objective understanding of the new technology to 
avoid unnecessary panic (http://world.people.com.cn/GB/ 
57507/11806145.html). An assessment from related ethical 
committee in U.S. said that currently synthetic biology will 
not produce huge unexpected destructive influence, but 
long-term supervision should be paid and appropriate meas-
ures should be formulated and implemented to avoid the risk. 
5  Summary and prospect 
It can be foreseen that, in the future, by using synthetic bi-
ology techniques, people will have artificial leafs to con-
sume carbon dioxide while producing green energy. As 
mentioned above, synthetic biology will have the big poten-
tial to address a wide range of application including medi-
cine, environment, energy, agriculture and so on. 
Synthetic biology is still in its infancy in China. How to 
make full use of the current achievements and to establish 
our own research platform for synthetic biology is one of 
the important issues we are facing. Meanwhile synthetic 
biology research in China should cater for the national 
needs aiming to benefit the whole society. Since synthetic 
biology is a cross-disciplinary field, researchers from dif-
ferent areas should strengthen communication and coopera-
tion to promote the development of synthetic biology in 
China. Scientists in China have the ability to make great 
achievements in this field and we look forward that syn-
thetic biology will bring great impact on our future eco-
nomical and social development.  
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